Literature DB >> 8639807

Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.

N D Gamboa de Domínguez1, P J Rosenthal.   

Abstract

Erythrocytic malaria parasites degrade hemoglobin as a source of amino acids for parasite protein synthesis. Cysteine proteinase inhibitors have been shown to block the hydrolysis of globin by cultured parasites, indicating that a malarial cysteine proteinase is required for this process. In the present study, we have evaluated the role of parasite proteinases in earlier steps of hemoglobin degradation, namely the disassociation of the hemoglobin tetramer and the separation of heme from globin. Hemoglobin did not spontaneously denature or release heme under the pH and reducing conditions of the malarial food vacuole, suggesting that parasite enzymatic activity is necessary for early steps in hemoglobin degradation. The incubation of cultured parasites with cysteine proteinase inhibitors inhibited the denaturation of hemoglobin and the release of heme from globin. These results suggest that, in addition to its role in globin hydrolysis, a malarial cysteine proteinase participates in the dissociation of the hemoglobin tetramer and the release of heme from globin. Thus, the malarial cysteine proteinase is a promising target for antimalarial chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639807

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Antimalarial synergy of cysteine and aspartic protease inhibitors.

Authors:  A Semenov; J E Olson; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

2.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

Authors:  P S Sijwali; B R Shenai; J Gut; A Singh; P J Rosenthal
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

3.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

4.  Cytostatic versus cytocidal activities of chloroquine analogues and inhibition of hemozoin crystal growth.

Authors:  Alexander P Gorka; John N Alumasa; Katy S Sherlach; Lauren M Jacobs; Katherine B Nickley; Jonathan P Brower; Angel C de Dios; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 5.  Proteases of malaria parasites: new targets for chemotherapy.

Authors:  P J Rosenthal
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

6.  In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.

Authors:  Shweta Sinha; Daniela I Batovska; Bikash Medhi; B D Radotra; Ashish Bhalla; Nadezhda Markova; Rakesh Sehgal
Journal:  Malar J       Date:  2019-12-16       Impact factor: 2.979

7.  Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.

Authors:  Shoba Subramanian; Markus Hardt; Youngchool Choe; Richard K Niles; Eric B Johansen; Jennifer Legac; Jiri Gut; Iain D Kerr; Charles S Craik; Philip J Rosenthal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

8.  Intracellular proteolysis of kininogen by malaria parasites promotes release of active kinins.

Authors:  Piero Bagnaresi; Nilana Mt Barros; Diego M Assis; Pollyana Ms Melo; Raphael G Fonseca; Maria A Juliano; João B Pesquero; Luiz Juliano; Philip J Rosenthal; Adriana K Carmona; Marcos L Gazarini
Journal:  Malar J       Date:  2012-05-07       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.